文献速递腹部MR

MRI上肝周间隙增宽及其他形态学特征预测肝纤维化的信度与准确性

Imaging Biomarkers of Hepatic Fibrosis: Reliability and Accuracy of Hepatic Periportal Space Widening and Other Morphologic Features on MRI.
PubMed 文献 · AJR Am J Roentgenol · 2021-03-17

单中心回顾性研究纳入229例接受肝MR弹性成像的患者,两名腹部放射科医师独立评估肝周间隙增宽等慢性肝病定性特征及其测量值。以MR弹性成像硬度为参考标准,肝周间隙增宽对任何肝纤维化的敏感度最高(83.0%),但特异度有限(61.3%);联合其他慢性肝病特征或单独表面结节时敏感度72.6%、特异度76.1%。

要点

  • 肝周间隙增宽对任何肝纤维化敏感度83.0%,特异度61.3%。
  • 表面结节对任何肝纤维化特异度94.4%,敏感度51.6%。
  • 主门静脉处肝周间隙>9.5 mm与定性增宽信度高度一致(κ=0.74)。

关键影像表现/征象

  • 肝周间隙增宽在MRI上作为慢性肝病的定性特征被评估。
  • 表面结节是慢性肝病的另一形态学特征。
  • 主门静脉处肝周间隙>9.5 mm与定性肝周间隙增宽信度高度一致(κ=0.74)。

诊断标准与关键数值

  • 肝周间隙增宽对任何肝纤维化(I期或以上)的敏感度83.0%、特异度61.3%。
  • 表面结节对任何肝纤维化的特异度94.4%、敏感度51.6%。
  • 肝周间隙增宽联合一个或多个其他慢性肝病影像特征或单独表面结节对任何肝纤维化的敏感度72.6%、特异度76.1%。
  • 肝周间隙增宽的观察者间信度中等(κ=0.47);其余特征信度中等至高度(κ=0.42-0.80)。
  • 主门静脉处肝周间隙测量信度中等(ICC=0.55),右门静脉处信度接近完美(ICC=0.83)。

临床应用与阅片要点

  • 肝周间隙增宽可作为提示肝纤维化的高敏感度定性征象,但需注意其特异度有限。
  • 联合其他慢性肝病形态学特征或表面结节可提高诊断特异度至76.1%。
  • 主门静脉处肝周间隙>9.5 mm可作为定性增宽的量化参考。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this article was to assess the reliability and accuracy of hepatic periportal space widening and other qualitative imaging features for the prediction of hepatic fibrosis. MATERIALS AND METHODS. This single-center retrospective study identified consecutive patients who had undergone liver MR elastography. Two abdominal radiologists independently reviewed anatomic images, assessing multiple qualitative features of chronic liver disease (CLD) including periportal space widening. Each reader also measured the periportal space at the main portal vein (MPV) and right portal vein (RPV). Interrater reliability analysis was then performed. Sensitivity and specificity were determined for the detection of any hepatic fibrosis (stage I or higher) and of advanced fibrosis (stage III or higher) using stiffness on MR elastography as the reference standard. RESULTS. Of 229 subjects, 157 (69%) had fibrosis and 78 (34%) had advanced fibrosis. Agreement for periportal space widening was moderate (κ = 0.47), and agreement for remaining features was moderate to substantial (κ = 0.42-0.80). Agreement for the periportal space at the MPV was moderate (ICC, 0.55), and agreement for the periportal space at the RPV was near perfect (ICC, 0.83). Periportal space widening had the highest sensitivity (83.0%) for any fibrosis, with limited specificity (61.3%). Surface nodularity had the highest specificity (94.4%) for any fibrosis, with limited sensitivity (51.6%). Periportal space widening plus one or more additional imaging feature of CLD or the presence of surface nodularity alone had sensitivity of 72.6% and specificity of 76.1%. A periportal space at the MPV greater than 9.5 mm had substantial agreement with qualitative periportal space widening (κ = 0.74). CONCLUSION. Periportal space widening has a high sensitivity for hepatic fibrosis, with moderate specificity when combined with additional anatomic features of CLD.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Ludwig DR, Fraum TJ, Ballard DH, et al. Imaging Biomarkers of Hepatic Fibrosis: Reliability and Accuracy of Hepatic Periportal Space Widening and Other Morphologic Features on MRI. AJR Am J Roentgenol. 2021. PMID: 33729883. doi:10.2214/AJR.20.23099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。